Hi-Clearance - Asset Resilience Ratio

Latest as of September 2025: 2.55%

Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 1788 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$127.12 Million
≈ $4.00 Million USD Cash + Short-term Investments

Total Assets

NT$4.99 Billion
≈ $157.20 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. See Hi-Clearance (1788) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1788 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$127.12 Million 2.55%
Total Liquid Assets NT$127.12 Million 2.55%

Asset Resilience Insights

  • Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hi-Clearance Industry Peers by Asset Resilience Ratio

Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Tellgen Corp
SHE:300642
Medical Devices 9.96%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%

Annual Asset Resilience Ratio for Hi-Clearance (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.63% NT$130.66 Million
≈ $4.12 Million
NT$4.96 Billion
≈ $156.28 Million
+0.23pp
2023-12-31 2.40% NT$110.86 Million
≈ $3.49 Million
NT$4.62 Billion
≈ $145.49 Million
+0.34pp
2022-12-31 2.06% NT$93.01 Million
≈ $2.93 Million
NT$4.51 Billion
≈ $142.05 Million
+0.72pp
2021-12-31 1.34% NT$59.55 Million
≈ $1.88 Million
NT$4.44 Billion
≈ $139.80 Million
-0.12pp
2020-12-31 1.47% NT$61.65 Million
≈ $1.94 Million
NT$4.20 Billion
≈ $132.42 Million
-0.55pp
2019-12-31 2.01% NT$75.07 Million
≈ $2.37 Million
NT$3.73 Billion
≈ $117.42 Million
-2.36pp
2018-12-31 4.38% NT$129.95 Million
≈ $4.09 Million
NT$2.97 Billion
≈ $93.55 Million
-1.10pp
2017-12-31 5.48% NT$143.14 Million
≈ $4.51 Million
NT$2.61 Billion
≈ $82.33 Million
-1.20pp
2016-12-31 6.68% NT$165.10 Million
≈ $5.20 Million
NT$2.47 Billion
≈ $77.85 Million
--
pp = percentage points

About Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$183.05 Million
NT$5.81 Billion TWD
Market Cap Rank
#16997 Global
#861 in Taiwan
Share Price
NT$130.50
Change (1 day)
+1.16%
52-Week Range
NT$129.00 - NT$144.50
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more